We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00226850
First Posted: September 27, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Stanford University
  Purpose
This study examined whether a hypnosis intervention, compared to standard care, could help reduce distress and pain for children undergoing an invasive medical procedure.

Condition Intervention Phase
Voiding Cystourethrogram (VCUG) Behavioral: hypnosis Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)

Further study details as provided by Stanford University:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • The child: (1) was scheduled for an upcoming VCUG ; (2) must have undergone at least one previous VCUG; (3) was at least 4 years of age at the time of the previous VCUG; (4) experienced distress during the previous VCUG; and (5) both child and participating parent were English speaking.

Exclusion Criteria:

  • Not meeting any of the above criteria.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00226850


Locations
United States, California
Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine
Stanford, California, United States, 94305-5718
Lucile Packard Children's Hospital
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Study Director: Lisa D. Butler, Ph.D. Stanford University
Principal Investigator: David Spiegel, M.D. Stanford University
Principal Investigator: Linda D Shortliffe, M.D. Stanford University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00226850     History of Changes
Other Study ID Numbers: 1HUK610
First Submitted: September 12, 2005
First Posted: September 27, 2005
Last Update Posted: December 9, 2005
Last Verified: September 2005